Percutaneous Ablation in the Kidney

Venkatesan, Aradhana M.; Wood, Bradford J.; Gervais, Debra A.

doi:10.1148/radiol.11091207

Cited by 109 publications

(64 citation statements)

References 95 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It also provides assessment of the overall treatment success and procedural complications. Most recommend obtaining unenhanced and contrastenhanced CT or MR images after ablation; however, controversies exist regarding how often and for how long imaging should be performed (Venkatesan et al 2011 ). Typically imaging is obtained at 3 and 6 months after ablation.…”

Section: Focal Therapymentioning

confidence: 99%

“…Areas of contrast enhancement at initial follow-up usually indicate residual viable RCC and primary treatment failure. The pattern of residual or recurrent tumours often manifests as a focus of nodular or crescentic enhancement on post ablation images (Zagoria 2004 ;Venkatesan et al 2011 ). Of note, attenuation of 10-20 HU can sometimes be seen following successful ablation, and, in cases of cryoablation, a thin peripheral rim of enhancement often persists for several months following therapy (Wile et al 2007 ).…”

Section: Focal Therapymentioning

confidence: 99%

“…Of note, attenuation of 10-20 HU can sometimes be seen following successful ablation, and, in cases of cryoablation, a thin peripheral rim of enhancement often persists for several months following therapy (Wile et al 2007 ). Enhancement or enlargement at subsequent imaging after initial negative imaging fi ndings is considered indicative of local tumour recurrence (Venkatesan et al 2011 ).…”

Section: Focal Therapymentioning

confidence: 99%

See 2 more Smart Citations

Female Pelvis: Genital Organs

Forstner

Cunha²

2015

Imaging of Complications and Toxicity Following Tumor Therapy

View full text Add to dashboard Cite

Medical Radiology-Diagnostic Imaging is a unique series that aims to document the most innovative technologies in all fi elds within diagnostic imaging and interventional radiology, thereby informing the physician in practice of the latest advances in diagnostic imaging and percutaneous imageguided minimally invasive procedures. Th e contents are intended to cover all organs, and all modern imaging techniques and image-guided treatment modalities, with special emphasis on applications in clinical practice. Each volume is a comprehensive reference book on a topical theme, and the editors are always experts of high international standing. Contributions are included from both clinicians and researchers, ensuring wide appeal. Medical Radiology -Radiation Oncology is a unique series that aims to document the most innovative technologies in all fi elds within radiology, thereby informing the physician in practice of the latest advances in diagnostic and treatment techniques. Th e contents range from contemporary statements relating to management for various disease sites to explanations of the newest techniques for tumor identifi cation and of mechanisms for the enhancement of radiation eff ects, with the emphasis on maximizing cure and minimizing complications. Each volume is a comprehensive reference book on a topical theme, and the editors are always experts of high international standing. Contributions are included from both clinicians and researchers, ensuring wide appeal. This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifi cally the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfi lms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specifi c statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. AbstractA precise knowledge of antineoplastic drugs is an indispensable basis for the care of patients with cancer. The mechanisms of action and resistance, cross-resistance patterns, pharmacodynamics and pharmacokinetics, pharmacological interaction, and last but not least potential adverse effects should be part of this knowledge. As contemporary cancer care requires interdisciplinary and multiprofessional structures, the radiologist is an important a...

show abstract

Section: Focal Therapymentioning

confidence: 99%

Section: Focal Therapymentioning

confidence: 99%

Section: Focal Therapymentioning

confidence: 99%

See 1 more Smart Citation

Female Pelvis: Genital Organs

Forstner

Cunha²

2015

Imaging of Complications and Toxicity Following Tumor Therapy

View full text Add to dashboard Cite

show abstract

“…It offers advantages over nephron-sparing surgery, including negligible surgical morbidity, minimal convalescence, and maximal preservation of renal function [2,3]. PCA is capable of treating SRMs in all patients regardless of age or comorbidity with oncologic outcomes approaching those of partial nephrectomy [4,5,6].…”

Section: Introductionmentioning

confidence: 99%

Pneumodissection: An Alternative Protective Technique for the Percutaneous Cryoablation of Small Renal Masses

et al. 2013

View full text Add to dashboard Cite

Introduction: Percutaneous cryoablation is an emerging treatment option for the small renal mass. It poses a risk of thermal injury to adjacent tissues, limiting its application. We describe pneumodissection, a novel technique for preventing thermal injury during percutaneous cryoablation. Materials and Methods: The cases of 4 patients who underwent percutaneous renal cryoablation and pneumodissection were retrospectively reviewed. Results: Pneumodissection mechanically separated four tumors from overlying bowel segments (mean distance 1.2 ± 0.4 cm), permitting successful cryoablation. There were no complications or recurrences with 7.5 months of follow-up. Conclusions: Pneumodissection is a feasible displacement technique that facilitates percutaneous cryoablation in at-risk patients. Further study is warranted.

show abstract

“…RFA in the kidney is now performed as a standard therapeutic nephron-sparing option in patients who are poor candidates for resection [10], but no report on the comparison of results of renal RFA between young and older A lot of information has been accumulated in the last 20 years through retrospective and prospective clinical trials in the various solid tumors for older patients requiring medical treatment. The results provide indications useful for the management of most tumor types in elderly patients.…”

mentioning

confidence: 99%